These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6743382

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
    Civeira F, Cenarro A, Ferrando J, Puzo J, Garcia-Otín AL, Mozas P, Pocoví M.
    Am Heart J; 1999 Jul; 138(1 Pt 1):156-62. PubMed ID: 10385780
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction.
    Schwartzkopff W, Schleicher J, Pottins I, Yu SB, Han CZ, Du DY.
    Atherosclerosis; 1990 Jun; 82(3):253-9. PubMed ID: 2375789
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. A phenocopy of type III dysbetalipoproteinemia occurring in a candidate family for a putative apo E receptor defect.
    Davignon J, Dallongeville J, Roederer G, Roy M, Fruchart JC, Kessling AM, Bouthillier D, Lussier-Cacan S.
    Ann Med; 1991 Apr; 23(2):161-7. PubMed ID: 1648930
    [Abstract] [Full Text] [Related]

  • 52. [Determination of plasma levels of apolipoprotein E and of HDL-cholesterol in gouty patients].
    Frati E, Castagna ML, Bacarelli M, Giordano N, Fioravanti A, Pucci G, Marcolongo R.
    Boll Soc Ital Biol Sper; 1984 May 30; 60(5):1063-9. PubMed ID: 6590073
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.
    Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ.
    J Lipid Res; 1982 Nov 30; 23(8):1224-35. PubMed ID: 7175379
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P.
    Kidney Int; 2002 Jan 30; 61(1):209-18. PubMed ID: 11786103
    [Abstract] [Full Text] [Related]

  • 60. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C.
    Atherosclerosis; 1995 Apr 07; 114(1):83-91. PubMed ID: 7605379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.